News

October has offered a striking spectacle of contrasts in Europe's ponderous attempts to construct a comprehensive policy on health.

This article delves into the why, when, and how a patient-centric approach should be adopted for both the benefit of patients and the successful development of novel and innovative medicines.

What technologies ease clinical trial laboratory sample and data management, and what are the benefits?

Dr. Tshaka Cunningham, Associate Director of Scientific Collaboration for DIA, will discuss his perspectives on advancements in gene editing therapies and their impact on the industry.

Updated employee announcements, business news, awards, and recognition in the industry today.

Advances in our understanding of the genetic, immunological, and environmental factors that contribute to the pathogenesis of psoriasis have led to the development of very effective precision therapies that alleviate patient morbidity and improve quality of life, especially for patients with moderate to severe disease.